The anti-diabetics market includes drugs, which are used for treatment of diabetes mellitus and are also known as oral hypoglycemic/antihyperglycemic agents. The anti-diabetics market has grown tremendously in recent years with increasing prevalence of diabetes mellitus. Thus, systemic therapies for diabetes have become the focal point of attention due to the burgeoning diabetic population size, with diabetes affecting middle age groups and children across all income groups globally.

Some of the major drivers and opportunities for growth of this market include drug combinations of several agents such as sitagliptin and metformin and other drug combinations that are in different stages of clinical and pipeline development. Increase in the prevalence of diabetes and new product launches by major pharmaceutical companies re some of the key drivers for growth in this market. In 2015, Boehringer Ingelheim GmbH launched two new drugs (Synjardy & Glyxambi)for treatment of diabetes mellitus type II.

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-antidiabetic-drugs-2019-407

Some of the key opportunities for the antidiabetics include a strong pipeline for antidiabetics and entry of new players in the market, for instance, Novo Nordisk’s diabetes drug’s Tresiba, and Ryzodeg received FDA approval in September 2015. Moreover, Boehringer Ingelheim GmbH has a strong pipeline for anti-diabetic drugs, such as Linagliptin which is a dipeptidyl peptidase (DPP) 4 inhibitor) for patients suffering from diabetes mellitus type II and high cardiovascular risk.

The global Anti-Diabetic Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019–2025.

This report focuses on Anti-Diabetic Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Diabetic Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:

• Astra Zeneca
• Boehringer Ingelheim
• Eli Lilly
• Johnson & Johnson
• Merck
• Novartis
• Novo Nordisk
• Sanofi
• Teva Pharmaceutical Industries

Segment by Regions

• North America
• Europe
• China
• Japan

Segment by Type

• Biguanides
• Sulfonylureas
• Meglitinides
• Thiazolidinediones
• Dipeptidyl Peptidase IV Inhibitors
• ?-Glucosidase Inhibitors

Segment by Application

• Type I Diabetes
• Type II Diabetes
• Others

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-antidiabetic-drugs-2019-407

Table of content

Executive Summary
1 Anti-Diabetic Drugs Market Overview
1.1 Product Overview and Scope of Anti-Diabetic Drugs
1.2 Anti-Diabetic Drugs Segment by Type
1.2.1 Global Anti-Diabetic Drugs Production Growth Rate Comparison by Type (2014–2025)
1.2.2 Biguanides
1.2.3 Sulfonylureas
1.2.4 Meglitinides
1.2.5 Thiazolidinediones
1.2.6 Dipeptidyl Peptidase IV Inhibitors
1.2.7 ?-Glucosidase Inhibitors
1.3 Anti-Diabetic Drugs Segment by Application
1.3.1 Anti-Diabetic Drugs Consumption Comparison by Application (2014–2025)
1.3.2 Type I Diabetes
1.3.3 Type II Diabetes
1.3.4 Others
1.4 Global Anti-Diabetic Drugs Market by Region
1.4.1 Global Anti-Diabetic Drugs Market Size Region
1.4.2 North America Status and Prospect (2014–2025)
1.4.3 Europe Status and Prospect (2014–2025)
1.4.4 China Status and Prospect (2014–2025)
1.4.5 Japan Status and Prospect (2014–2025)
1.5 Global Anti-Diabetic Drugs Market Size
1.5.1 Global Anti-Diabetic Drugs Revenue (2014–2025)
1.5.2 Global Anti-Diabetic Drugs Production (2014–2025)

2 Global Anti-Diabetic Drugs Market Competition by Manufacturers
2.1 Global Anti-Diabetic Drugs Production Market Share by Manufacturers (2014–2019)
2.2 Global Anti-Diabetic Drugs Revenue Share by Manufacturers (2014–2019)
2.3 Global Anti-Diabetic Drugs Average 

Find Related Reports :

1)Global Diabetic Therapeutic Drugs Market Research Report 2018 by Manufacturers, Regions, Types and Applications

2)Asia-Pacific Diabetic Therapeutic Drugs Market Report 2018

3) Europe Diabetic Therapeutic Drugs Market Report 2018

CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 646 781 7170 / +91 8087042414
Email: help@grandresearchstore.com

Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/